Scientists in Israel based daily Ha’aretz, according to some quoting medical sources, reported on Thursday that scientists based in Israel’s Institute for Biological Research directly have made a noteworthy breakthrough under the supervision of the Prime Minister’s office, toward the biological mechanism along with the qualities of the virus. It also entails enhanced diagnostic potential and the invention of antibodies for those who by now have the coronavirus.
Though the development process might linger on as it might require a series of tests and experiments that may last many months before the vaccination is launched. However, the Defense Ministry did not confirm the news so far.
The biological institute is designated as a world-renowned research and development agency, which totally depends on the faculty of experienced researchers and scientists having great knowledge and quality infrastructures. It is implicit that more than 50 skilled scientists are effective at the institute on exploring and mounting a medical therapy for the virus.
Institute is located in the central Israeli town of Nes Tziona, it was established in 1952 as part of the Israel Defense Forces’ Science Corps, and later on, declared as a civilian organization.
It is working in collaboration with the Defense Ministry as well.
Generally, the process of development of vaccines requires pre-clinical trials on animals, followed by clinical trials. Keeping in view global emergency condition the development of such a vaccine should be expedited to save as many as possible.
As told by the trendy news portal, Ynet accounts five deliveries of virus samples arrived here from Japan and Italy three weeks before.
China already released the genetic sequence of the virus on open scientific databases very shortly after its outbreak in January so that research institutes and commercial companies should try to develop treatments and vaccines to avoid any delays due to the requirement of samples.
Ha’aretz reported that almost 1.5 months later, Boston based, Massachusetts biotechnology company Moderna, Inc., claimed the development of a possible coronavirus vaccine.
Then the vaccine was sent to the US National Institute of Allergy and Infectious Diseases, along with clinical trials, which will include up to 25 health participants to start in April.
The same procedure is expected to be followed by the Israeli Scientists.